Cyclic peptidomimetic for the treatment of neurological disorders
WO2021062124A2
Methods and compositions for treating, preventing or reversing obesity and obesity-related disorders by opsin 3 regulation of hypothalamic melanocortin receptors
WO2021050856A1
Multi-message multi-user signature aggregation
US2021076502A1
High speed multi-directional three dimensional printer
US2021024457A1
Diamide antimicrobial agents
WO2021011293A1
Location information from a receiver in a wireless network
US2020367749A1
Implantable wireless network of distributed microscale sensors
WO2020232436A1
A human in vitro cardiotoxicity model
WO2020227431A1
Bispecific antibodies against chi3l1 and pd1 with enhanced t cell-mediated cytotoxic effects on tumor cells
US2020353046A1
Compositions and methods to enhance cutaneous wound healing
WO2020214987A1
Neurogenesis
US2020368160A1
Antifungal nanoparticles for targeted treatment of fungal infections
WO2020198247A1
Nanoparticle catalyst for synthesizing polybenzoxazole with controlled polymerization
US2020297898A1
Auranofin releasing antibacterial and antibiofilm polyurethane intravascular catheter coatings
US2020370008A1
Placental lipid bilayer for cell-free molecular interaction studies
US2020253491A1
Mobile Wearable Combinatorial Ultrasound/Near Infrared Sensor System
US2020253479A1
High spatiotemporal resolution brain imaging
WO2020154656A1
Compositions and methods for treating, preventing or reversing age-associated inflammation and disorders
WO2020146676A1
A multi-compartment device containing human three-dimensional (3d) microtissues for toxicity testing
